CHAPEL HILL, N.C., April 8, 2016 /PRNewswire/ -- Big Data has the potential to generate valuable insights for key commercial decisions within the biopharmaceutical industry. Despite this, biopharmaceutical organizations have been slower than other industries to embrace Big Data analytics. Big Data/Real World Analytics can be the catalyst for dramatic change in U.S. healthcare if adopted properly.
Although biopharma organizations have been slow to invest in Big Data for various reasons, this trend is appearing to change. According to recent research, between 30-40% of participants said they expect their data capabilities to increase over the next two years.
The related report, "Big Data in Pharma: Current & Future Trends for Big Data Utilization Across Commercial Function," will help leaders to better understand the growing influence of Big Data in the biopharmaceutical sector and how it impacts medical, HEOR, and commercial operations in the United States.
Key study topics include:
- Types of Big Data Projects Used to Support Medical, Commercial and HEOR Decisions
- Big Data Capabilities and Governance
- Types and Value of Data Used for Big Data Projects
- Big Data Staffing and Budget Levels
- Value Rating of Partnerships on Big Data Projects
- Policies and Procedures Governing Big Data Activities
To access the full report, or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/re2853.htm
For more information on other recent primary research studies, contact us at 919.403.0251. For related research, visit our Best Practices, LLC website at http://www.best-in-class.com/
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/current--future-trends-in-pharmaceutical-big-data-across-commercial-functions-300248550.html
SOURCE Best Practices, LLC